Legato Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $898K | Buy |
+48,185
| New | +$898K | 0.11% | 307 |
|
|
2025
Q1 | – | Sell |
-20,335
| Closed | -$732K | – | 619 |
|
|
2024
Q4 | $732K | Buy |
20,335
+6,530
| +47% | +$235K | 0.1% | 373 |
|
|
2024
Q3 | $585K | Sell |
13,805
-15,065
| -52% | -$639K | 0.07% | 422 |
|
|
2024
Q2 | $1.16M | Buy |
28,870
+10,845
| +60% | +$437K | 0.16% | 218 |
|
|
2024
Q1 | $638K | Buy |
18,025
+7,215
| +67% | +$255K | 0.08% | 383 |
|
|
2023
Q4 | $320K | Buy |
+10,810
| New | +$320K | 0.04% | 485 |
|
|
2023
Q3 | – | Sell |
-14,676
| Closed | -$360K | – | 646 |
|
|
2023
Q2 | $360K | Buy |
14,676
+3,849
| +36% | +$94.5K | 0.05% | 473 |
|
|
2023
Q1 | $440K | Sell |
10,827
-4,785
| -31% | -$194K | 0.08% | 378 |
|
|
2022
Q4 | $702K | Buy |
+15,612
| New | +$702K | 0.13% | 260 |
|